
TrialKey provides data-driven design for clinical trials to improve speed and success. It uses AI and machine learning with biostatistical validation to automate protocol creation, optimize criteria, and simulate outcomes. The platform is a SaaS solution that analyzes 520k+ trials, 1,500+ variables, and performs up to 100,000 simulations. It supports CROs, sponsors, and biopharma in achieving regulatory alignment and scalable trial design. Key technologies include AI, ML, predictive analytics, NLP/LLMs, and biostatistical validation.

TrialKey provides data-driven design for clinical trials to improve speed and success. It uses AI and machine learning with biostatistical validation to automate protocol creation, optimize criteria, and simulate outcomes. The platform is a SaaS solution that analyzes 520k+ trials, 1,500+ variables, and performs up to 100,000 simulations. It supports CROs, sponsors, and biopharma in achieving regulatory alignment and scalable trial design. Key technologies include AI, ML, predictive analytics, NLP/LLMs, and biostatistical validation.